ANTIPSYCHOTIC POTENTIALS OF OCIMUM SANCTUM LEAVES
Abstract
The present study was undertaken to evaluate the antipsychotic potential of Ocimum sanctum in experimental animal models. Male Wistar rats (180-220 g) and albino mice (25-30 g) were used for the study. The antipsychotic effect of the Ocimum sanctum was evaluated on haloperidol induced catalepsy, cooks pole climbing apparatus, locomotor activity on actophotometer, ketamine induced stereotype behavior. Different groups of rats were fed orally with a specially prepared diet containing various concentrations (2% w/w, 4% w/w and 8% w/w) of Ocimum sanctum leaves paste (OCLP) for 15 consecutive days. Further, the biochemical estimations were done by estimating brain dopamine levels. The OCLP produced significant dose dependent potentiation of haloperidol (1mg/kg, i.p.) induced catalepsy in rats, significantly increased the time taken by the rat to climb the pole in dose dependent manner, significantly decreased the locomotor activity. The OCLP significantly decreased ketamine (50 mg/kg, i.p.) induced stereotyped behavior in a dose dependent manner. Ocimum sanctum leaves paste (OCLP) significantly decreased the brain dopamine levels. The results suggest that OCLP posse’s antipsychotic activity. Further neurochemical investigation can explore the mechanism of action of the plant drug with respect to anti-dopaminergic functions and help to establish the plant as an antipsychotic agent.
Keywords:
Anti-dopaminergic, catalepsy, stereotype, ketamineDOI
https://doi.org/10.25004/IJPSDR.2015.070108References
2. Mondal S, Bijay R, Miranda RB, Sushil CM. The Science behind Sacredness of Tulsi (Ocimum sanctum LINN.). Ind. J. Physiol. Pharmacol. 2009; 53: 291–306.
3. Vishwabhan S, Birendra VK, Vishal S. A Review on Ethnomedical uses of Ocimum sanctum (Tulsi). Int. Res. J of Pharm. 2011; 2: 1-3.
4. Jeba CR, Vaidyanathan R, Kumar RG. Immunomodulatory activity of aqueous extract of Ocimum sanctum in rat. Int. J. Pharmaceu. and Biomed. Res. 2011; 2: 33-38.
5. Kadian R, Parle M. Therapeutic Potential and Phytopharmacology of tulsi. Int. J. of Pharm. & Life Sci. 2012; 3(7):1858-1867.
6. Giridharan VV, Thandavarayan RA, Mani V, Ashok Dundapa TA, Watanabe K, Konishi T. Ocimum sanctum Linn. leaf extracts inhibit acetylcholinesterase and improve cognition in rats with experimentally induced dementia. J.Med. Food. 2011; 14:912-9.
7. Lahon K, Das S. Hepatoprotective activity of Ocimum sanctum alcoholic leaf extract against paracetamol-induced liver damage in Albino rats. Pharmacognosy Res. 2011; 3:13-18.
8. Milind P, Renu K. Behavioral Models of Psychosis, Int. Res. J. of Pharm. 2013; 4: 26-30.
9. Milind P, Renu K, Kaura S. Non-behavioral Models of Psychosis. Int. Res. J. of Pharm.2013; 4:89-95.
10. Hashimoto A, Yoshikawa M, Niwa A, Konno R. Mice lacking D-amino acid oxidase activity display marked attenuation of ste¬reotypy and ataxia induced by MK-801. Brain Res. 2005; 1033:210-215.
11. Bhosale AU, Yegnanarayan, Pophale DP, Zambare RM, Somani SR. Study of central nervous system depressant and behavioral activity of an ethanol extract of Achyranthes aspera (Agadha) in different animal models. Int. J. of App. and Bas. Med. Res. 2011; 1: 104-108.
12. Ansell GB, Beeson MF. A rapid and sensitive procedure for the combined assay of noradrenalin, dopamine and Serotonin in a single brain sample. Anal. Biochem. 1968; 23:196-206.
13. Cox RH, Perhach JL. A sensitive, rapid and simple method for the simultaneous spectrophotofluorometric determination of norepinephrine, dopamine, 5-hydroxytryptamine and 5-Hydroxy-indoleacetic acid in discrete areas of brain. J. of Neurochem. 1973; 20:1777-1780.
14. Herbert YM. Neuropharmacology: The fifth generation of progress, Am Coll Neuropharmacology. 2002; 1: 819-822.
15. Costall B, Naylor RJ, Olley JE. Cataleptic and circling behavior after intracerebral injections of Neuroleptic, cholinergic and anticholinergic agents into the caudate putamen, glopus pallidus and substantia nigra of rat brain. Neuropharmacology. 1972; 11: 645-663.
16. Seema P, Tallerico T. Rapid Release of Antipsychotic Drugs from Dopamine D2 Receptors: An Explanation for Low Receptor Occupancy and Early Clinical Relapse Upon Withdrawal of Clozapine or Quetiapine. Am. J. Psychiatry. 1999; 156: 876-884.
17. Seema P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnoght GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yani K, Weinshenker D, Sumiyoshi T. Psychosis pathway converge via D2high dopamine receptors, Synapase. 2006; 60: 319-346.
Published
Abstract Display: 539 
PDF Downloads: 469 
